Physician profile
Jonathan E Moore
NPI 1558339440
$627.34
in general payments reported to CMS, 2019-2025
11 companies · $114 in 2025
The $114 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $91.26 · 2020: $105 · 2021: $25.52 · 2022: $142 · 2023: $149 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $263.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $207.82 | 2022-2023 | Puraply |
| Horizon Therapeutics Plc | $93.24 | 2019-2022 | |
| Boston Scientific Corporation | $79.38 | 2020 | |
| Merck Sharp & Dohme LLC | $56.66 | 2019-2023 | Recarbrio, Zerbaxa, Dificid |
| Amgen INC. | $47.61 | 2025 | Krystexxa |
| Smith+Nephew, INC. | $37.23 | 2022-2023 | Collagenase Santyl |
| Reapplix INC. | $26.02 | 2025 | 3c Patch Kit - Box |
| Stryker Corporation | $25.20 | 2020 | |
| Convatec INC. | $22.74 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $18.03 | 2025 | |
| Abbvie INC. | $13.41 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.